Bi Wenya Linda, Dunn Ian F
Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S7. doi: 10.21037/cco.2017.06.10.
Surgery continues to be the preferred method to treat meningioma. Recent advancements in the understanding of meningioma biology, including a new appreciation for remarkable molecular heterogeneity in these tumors, has sharpened the drive for disease control, especially on initial diagnosis. Microsurgical and skull base techniques and principles dominate the surgical approaches for meningiomas. At the same time, biologic tools may improve the extent of surgical resection as well as provide novel adjuvant therapy options for challenging meningiomas.
手术仍然是治疗脑膜瘤的首选方法。对脑膜瘤生物学认识的最新进展,包括对这些肿瘤显著分子异质性的新认识,增强了控制疾病的动力,尤其是在初始诊断时。显微外科和颅底技术及原则主导着脑膜瘤的手术方法。与此同时,生物学工具可能会提高手术切除的范围,并为具有挑战性的脑膜瘤提供新的辅助治疗选择。